Designing Two-Dimensional Nanosheets for Improving Drug Delivery to Fucose-Receptor-Overexpressing Cancer Cells
作者:Nitin Gupta、Ashok Kumar Jangid、Mandeep Singh、Deep Pooja、Hitesh Kulhari
DOI:10.1002/cmdc.201800575
日期:2018.12.20
Targeted drug delivery has shown promise in improving the therapeutic efficacy of anticancer drugs. Gemcitabine hydrochloride (GEM) is a broad‐range chemotherapeutic agent for the treatment of various cancers. However, systemic use of free GEM is restricted because of its poor physicochemical properties and nonspecific drug delivery, resulting in dose‐dependent adverse effects. In this study, a fucose‐conjugated
靶向药物递送在改善抗癌药物的治疗功效中显示出希望。盐酸吉西他滨(GEM)是用于治疗各种癌症的广泛化疗药物。但是,由于游离GEM的理化性质较差和药物的非特异性传递,因此全身使用受到限制,导致剂量依赖性不良反应。在这项研究中,基于岩藻糖缀合的氧化石墨烯(GO)的智能靶向纳米载体系统旨在为癌细胞提供高负荷,持续释放和靶向高浓度的GEM。制备了岩藻糖偶联的GO纳米片(FGONS)和载有GEM的岩藻糖偶联的GO纳米片(GEM-FGONS),并通过各种技术对其进行了表征。大约36.2%的GEM装载到FGONS,在48小时内显示出pH依赖性释放。发现GEM-FGONS的胶体悬浮液在长达96 h的理化状态下是稳定的。在细胞毒性研究中,GEM-FGONS对过量表达岩藻糖受体的MDA-MB-231人乳腺癌细胞和A549人肺癌细胞表现出时间和剂量依赖性的高毒性。此外,靶向制剂比非靶向或游离GEM更有效。总体而言